Rodman & Renshaw Maintains Market Outperform Rating and $5 PT on AMR

A report from Rodman & Renshaw reiterates its Market Outperform rating and $5 price target on AMR Corp. AMR. The report states, “Over the weekend, the APA released a negotiations update which indicated that “no future meetings with the company are scheduled.” It's unclear why a schedule for fast pace negotiations wasn't settled & mgmt provided no further comment. The stalemate comes after both sides had indicated in mid-November that a deal was potentially days away.” AMR closed Friday at $1.61.